273 related articles for article (PubMed ID: 12650783)
1. Low dose methotrexate in inflammatory bowel disease: current status and future directions.
Schröder O; Stein J
Am J Gastroenterol; 2003 Mar; 98(3):530-7. PubMed ID: 12650783
[TBL] [Abstract][Full Text] [Related]
2. Experience with the use of low-dose methotrexate for inflammatory bowel disease.
Soon SY; Ansari A; Yaneza M; Raoof S; Hirst J; Sanderson JD
Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):921-6. PubMed ID: 15316419
[TBL] [Abstract][Full Text] [Related]
3. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
4. Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease.
Vandell AG; DiPiro JT
Pharmacotherapy; 2002 May; 22(5):613-20. PubMed ID: 12013360
[TBL] [Abstract][Full Text] [Related]
5. [Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
Gomollón F; Rubio S; Charro M; García-López S; Muñoz F; Gisbert JP; Domènech E;
Gastroenterol Hepatol; 2015 Jan; 38(1):24-30. PubMed ID: 25454602
[TBL] [Abstract][Full Text] [Related]
6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of methotrexate in inflammatory bowel disease.
Gabbani T; Deiana S; Lunardi S; Manetti N; Annese V
Expert Opin Drug Saf; 2016 Oct; 15(10):1427-37. PubMed ID: 27462711
[TBL] [Abstract][Full Text] [Related]
8. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
Sedano Muñoz R; Quera Pino R; Ibáñez Lazo P; Figueroa Corona C; Flores Pérez L
Gastroenterol Hepatol; 2019 May; 42(5):339-347. PubMed ID: 30954317
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of inflammatory bowel disease therapies.
Sandborn WJ; Faubion WA
Curr Gastroenterol Rep; 2000 Dec; 2(6):440-5. PubMed ID: 11079044
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate: should we start using it in clinical practice?
Miheller P; Kiss LS; Mandel M; Lakatos PL
Curr Drug Targets; 2013 Nov; 14(12):1480-9. PubMed ID: 23651163
[TBL] [Abstract][Full Text] [Related]
11. [Classical medications in the treatment of inflammatory bowel diseases].
Duvnjak M; Bilić A; Barsić N; Tomasić V; Stojsavljević S
Acta Med Croatica; 2013 Apr; 67(2):111-24. PubMed ID: 24471294
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate: first-line or second-line immunomodulator?
Fraser AG
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):225-31. PubMed ID: 12610315
[TBL] [Abstract][Full Text] [Related]
13. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K
Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545
[TBL] [Abstract][Full Text] [Related]
14. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
15. [Conservative therapy of inflammatory bowel diseases].
Nagy F
Orv Hetil; 2002 Dec; 143(50):2763-8. PubMed ID: 12583315
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
18. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
19. [Role of thiopurine agents in ulcerative colitis].
Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
[TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Bischoff A
MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
